PHIA Koninklijke Philips N.V.

Philips debuts new emergency care informatics suite in U.S. market at HIMSS 2020

Philips debuts new emergency care informatics suite in U.S. market at HIMSS 2020

March 3, 2020

  • Now with FDA 510(K) clearance, web-based dashboard supports real-time data transfer to empower clinical decision-making in emergency care
  • Enhanced bidirectional feedback between first responders in the field and clinicians in the hospital helps improve patient care

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the U.S. launch of its pre-hospital informatics solution to provide real-time, bidirectional feedback between emergency responders on the scene and doctors in the hospital awaiting the arrival of the patient. The combination of Philips’ rugged, advanced vital signs monitor and its new emergency care informatics web-based dashboard enables emergency teams to capture and transmit clinical data to remote specialists, allowing the team at the hospital to immediately review a patient’s vitals and plan for their arrival. The solution aims to help emergency responders provide the best care possible in unpredictable pre-hospital environments.

Evolving EMS role currently outpacing evolving technology

The role of Emergency medical services (EMS) has evolved drastically, as they now face both clinical and operational challenges in trying to address the needs of patients. Caregivers experience unpredictable workloads in uncontrolled situations with the expectation they will diagnose, treat and transport patients where necessary. Challenges are exacerbated by lagging technological advancements, particularly in relation to flexibility of use and data acquisition. Monitors and defibrillators are typically bulky and heavy, while data collection remains a predominantly manual and retrospective process. Data automation and more reliable communication capabilities, paired with smaller and lighter monitors, can empower emergency responders to provide care closer to home, avoid unnecessary transports, and better allocate resources, helping to achieve the quadruple aim of improved outcomes, enhanced satisfaction for caregivers and patients, and reduced costs.

“Emergency medical service personnel are increasingly sharing that the rising demands placed on first responders coupled with the challenging and diverse cases they see require improved technology to meet patient needs,” said Arman Voskerchyan, General Manager for Therapeutic Care at Philips. “Emergency care is no longer just about resuscitation – there are higher incidences of cardiovascular disease, increasing co-morbidities, and a rapidly growing aging population. With these changes, EMS providers need better access to data and resources to help them adapt and equip them with the information needed to save lives.”

Making its debut in the U.S. at HIMSS 2020, the solution has already been in use in Europe, helping care teams spot life-threatening conditions remotely, improve accuracy of support from on-scene crews, and enhance tailoring of in-hospital care based on pre-hospital physiology.

Philips Portfolio in Emergency Care

In October 2019, Philips where helicopter Emergency Service (HEMS) teams were able to live stream patient medical information from the scene to the hospital through the Philips pre-hospital solution. Philips offers a range of emergency care offerings, including automated external defibrillators (AEDs), advanced life support monitors, and more.

For more information on Philips’ full portfolio of integrated smart enterprise systems, devices, software and services that will be spotlighted in Booth #2701 at the HIMSS Global Conference & Exhibition in Orlando, FL, Mar. 9 -13, 2020, visit and follow for #HIMSS2020 updates throughout the event.

For further information, please contact:

Kathy O’Reilly

Philips Global Press Office

Tel.:

E-mail:

Twitter:

Silvie Casanova

Philips North America

Tel:

Email:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments

EN
03/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips launches RADIQAL study to generate real-world evidence for new...

Philips launches RADIQAL study to generate real-world evidence for new ultra-low X-ray dose technology in coronary procedures May 20, 2025 Prospective, randomized, unblinded, comparative, international, multi-center clinical investigation824 patients across 6 hospitals in Spain, Czech Republic, Denmark and the USPrimary objective is to demonstrate that the new technology can reduce overall patient radiation dose without affecting coronary procedure performance. Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the (R...

 PRESS RELEASE

Philips launches real-time 3D intracardiac imaging in Europe, expandin...

Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures May 19, 2025 VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D and 3D images in real timeCatheter offers enhanced procedural guidance without the need for general anesthesia, supporting more efficient and patient-friendly care for structural heart disease Amsterdam, the Netherlands – (NYSE: PHG...

 PRESS RELEASE

Philips successfully prices offering of Notes for EUR 1 billion to be ...

Philips successfully prices offering of Notes for EUR 1 billion to be used for repayment of existing debt and to finance eligible green projects May 15, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 500 million fixed rate notes due 2030 and EUR 500 million fixed rate notes due 2035 (the “Notes”) under its European Medium Term Note (EMTN) program. The net proceeds will be used for general corporate purposes, the repayment of 2026 debt maturities, and to refinance or finance any ...

 PRESS RELEASE

Philips Future Health Index 2025: AI poised to transform global health...

Philips Future Health Index 2025: AI poised to transform global healthcare, urging leaders to act now May 15, 2025AI has the power to cut care delays and manage data overload, but trust gaps among clinicians and patients threaten to slow adoption and impactAmsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, , highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare professionals and patients, indicates AI holds promise for transforming care delivery. H...

Koninklijke Philips N.V.: 1 director

A director at Koninklijke Philips N.V. bought 8,176 shares at 24.410USD and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch